Tomasević, Ratko

Link to this page

http://vinar.vin.bg.ac.rs/APP/faces/author.xhtml?author_id=f4d283ea-129f-4b66-b565-5953407fa88b&item_offset=0&project_offset=0&sort_by=dc.date.issued
Authority KeyName Variants
f4d283ea-129f-4b66-b565-5953407fa88b
  • Tomasević, Ratko (1)
Projects
No records found.

Author's Bibliography

Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD

Mitrović, Bojan; Samardžić, Vladimir; Gluvić, Zoran; Tomasević, Ratko; Obradović, Milan; Sudar-Milovanović, Emina; Isenović, Esma R.

(2021) 

TY  - CONF
AU  - Mitrović, Bojan
AU  - Samardžić, Vladimir
AU  - Gluvić, Zoran
AU  - Tomasević, Ratko
AU  - Obradović, Milan
AU  - Sudar-Milovanović, Emina
AU  - Isenović, Esma R.
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12030
AB  - Introduction  Non-alcoholic fatty liver disease (NAFLD) is a component of metabolic syndrome (MetS). Hence, it is frequently associated with type 2 diabetes mellitus (T2DM). The low-grade inflammation associated with NAFLD usually explained the changes in serum iron metabolism. This study aims to assess the link between liver steatosis severity and serum iron, ferritin, and transferrin levels.  Material and methods  A case-control study involved 30 non-obese subjects (BMI 18.5–30 kg/m2), who suffered from T2DM for less than 5 years. Such subjects are regularly under treatment by metformin (M) and sulphonylurea (SU) derivates. Liver steatosis severity is determined by ultrasonography and presented as grades 1, 2, and 3 (initial, moderate, and advanced liver steatosis), respectively, according to Singh et al. criteria (Singh et al. Indian J Endocr Metab 2013;17: 990–5).  Results  In the observed population, 14 (47%), 11 (36%), and 5 (17%) subjects are determined to grade 1, 2, and 3 liver steatosis severity groups, respectively. The mean values of iron homeostasis markers have not differed from normal values. Liver steatosis severity grades positively correlated with serum ferritin levels, and this correlation is not revealed in the cases with serum iron and transferrin levels.  Conclusion  The low grade of liver steatosis has predominated in non-obese T2DM subjects under treatment with M and SU, irrespective of glycemic control quality. An increase in liver steatosis severity follows the ascending trend of ferritin levels. Further studies are needed to elucidate the impact of the quality of T2DM control on liver steatosis severity and iron metabolism markers.
C3  - Endocrine Abstracts
T1  - Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD
DO  - 10.1530/endoabs.73.AEP294
ER  - 
@conference{
author = "Mitrović, Bojan and Samardžić, Vladimir and Gluvić, Zoran and Tomasević, Ratko and Obradović, Milan and Sudar-Milovanović, Emina and Isenović, Esma R.",
year = "2021",
abstract = "Introduction  Non-alcoholic fatty liver disease (NAFLD) is a component of metabolic syndrome (MetS). Hence, it is frequently associated with type 2 diabetes mellitus (T2DM). The low-grade inflammation associated with NAFLD usually explained the changes in serum iron metabolism. This study aims to assess the link between liver steatosis severity and serum iron, ferritin, and transferrin levels.  Material and methods  A case-control study involved 30 non-obese subjects (BMI 18.5–30 kg/m2), who suffered from T2DM for less than 5 years. Such subjects are regularly under treatment by metformin (M) and sulphonylurea (SU) derivates. Liver steatosis severity is determined by ultrasonography and presented as grades 1, 2, and 3 (initial, moderate, and advanced liver steatosis), respectively, according to Singh et al. criteria (Singh et al. Indian J Endocr Metab 2013;17: 990–5).  Results  In the observed population, 14 (47%), 11 (36%), and 5 (17%) subjects are determined to grade 1, 2, and 3 liver steatosis severity groups, respectively. The mean values of iron homeostasis markers have not differed from normal values. Liver steatosis severity grades positively correlated with serum ferritin levels, and this correlation is not revealed in the cases with serum iron and transferrin levels.  Conclusion  The low grade of liver steatosis has predominated in non-obese T2DM subjects under treatment with M and SU, irrespective of glycemic control quality. An increase in liver steatosis severity follows the ascending trend of ferritin levels. Further studies are needed to elucidate the impact of the quality of T2DM control on liver steatosis severity and iron metabolism markers.",
journal = "Endocrine Abstracts",
title = "Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD",
doi = "10.1530/endoabs.73.AEP294"
}
Mitrović, B., Samardžić, V., Gluvić, Z., Tomasević, R., Obradović, M., Sudar-Milovanović, E.,& Isenović, E. R.. (2021). Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD. in Endocrine Abstracts.
https://doi.org/10.1530/endoabs.73.AEP294
Mitrović B, Samardžić V, Gluvić Z, Tomasević R, Obradović M, Sudar-Milovanović E, Isenović ER. Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD. in Endocrine Abstracts. 2021;.
doi:10.1530/endoabs.73.AEP294 .
Mitrović, Bojan, Samardžić, Vladimir, Gluvić, Zoran, Tomasević, Ratko, Obradović, Milan, Sudar-Milovanović, Emina, Isenović, Esma R., "Serum ferritin levels correlate with ultrasonography-determined liver steatosis severity in type 2 diabetes patients with NAFLD" in Endocrine Abstracts (2021),
https://doi.org/10.1530/endoabs.73.AEP294 . .
1